... Transdermal System, Mylan Technologies, Inc, Approval HalfLytely (bisacodyl, polyethylene glycol 3350, potassium chloride, sodium bicarbonate and sodium chloride) Delayed-Release Tablet, Braintree Laboratories, Inc, Efficacy Supplement with Clinical Data to Support Montelukast Sodium Chewable Tablets, Torrent Pharmaceuticals Ltd, Tentative Approval Mycophenolate Mofetil Tablets, Endo Pharmaceuticals Inc, Approval Omeprazole Delayed-Release Tablets, Dexcel Pharma Technologies Ltd, Labeling Revision Phentermine Hydrochloride Capsules, Lannett Holdings, Inc, Approval Tygacil (tigecycline) I.V. Injection, Pfizer Pharmaceuticals, Inc, Labeling Revision Veltin (clindamycin phosphate and tretinoin) Gel, Stiefel, a GSK Co, Approval Zyvox (linezolid) Injection, Pfizer Global Pharmaceuticals, Labeling Revision Zyvox (linezolid) Oral Suspension, Pfizer Global Pharmaceuticals, Labeling Revision Zyvox (linezolid) Tablets, Pfizer Global Pharmaceuticals, Labeling Revision July 16, 2010 Accolate (zafirlukast) Tablets, AstraZeneca Pharmaceuticals, LP, Labeling Revision Bupropion Hydrochloride Extended-Release Tablets, Mylan Pharmaceuticals, Inc, Approval Ergocalciferol Capsules, SigmaPharm Laboratories, LLC, Approval Mirapex ER (pramipexole dihydrochloride) Extended-Release Tablets, Boehringer Ingelheim Pharmaceuticals, ...